We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Price loading...
Springer Targeted Cancer Immune Therapy
Price data last checked 104 day(s) ago - refreshing...
Price History & Forecast
No Price Data Available
Price history will appear here once data is collected from Amazon.
Price Distribution
No price data available for histogram
Description
Product Description This comprehensive book covers novel immune therapeutic approaches, including cytokine therapy, engineered cell therapy, and the application of tumor-targeted antibodies for generating tumor-specific cell therapy, TLR ligand therapy and cytokine therapy. From the Back Cover Cancer has surpassed heart disease as the number one killer in the world, and standard cancer therapy such as radiation, chemotherapy, and surgery may have reached its plateau in further improving the outcome of treated patients. Biological therapies combined with other treatment approaches may be the next X-factor to greatly extend survival time and improve patients’ quality of life. One of the most developed fields in biological therapy is immune therapy, which has stemmed into many branches due to its significance and the tremendous effort by a large population of scientists. Tumor-targeted antibody therapy has been successfully used for treating some types of tumors, and the first tumor vaccine against ovarian cancer has been developed for clinical application. Targeted Cancer Immune Therapy provides comprehensive coverage of novel immune therapeutic approaches, including cytokine therapy, engineered cell therapy, and the application of tumor-targeted antibodies for generating tumor-specific cell therapy, TLR ligand therapy, and cytokine therapy. In the section "Cytokine Immune Therapy," the authors review relatively new cytokine family members, such as the IL12 family, IL18, IL21, IL24, IL28, and IL29, in regard to the anti-tumor function and application in treating tumors. The strategy for targeting and retaining cytokines in the tumor microenvironment is also reviewed. The section "Cell-based Immune Therapy" focuses on reviewing "state of the art" approaches for engineering potent immune regulatory or effector cells, such as dendritic cells, T cells, and stem cells, for tumor targeting and initiation of tumor specific immune response. In the section "Targeted Immune Therapy," the authors rearticulate antibody therapy for boosting immune response, which includes immunocytokines, "T-body," and tumor targeted CpG ODN. Some or all of these innovative approaches may ultimately become effective future immune therapies for treating malignancy.
Product Specifications
- Brand
- Springer
- Format
- paperback
- ASIN
- 1493939912
- Domain
- Amazon UK
- Release Date
- 23 August 2016
- Listed Since
- 26 May 2016
Barcode
No barcode data available
Similar Products You Might Like
96% match
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
Springer
£108.91
20 Apr 2026
96% match
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
Springer
£113.48
18 Apr 2026
95% match
Springer - Immunotherapy of Cancer: An Innovative Treatment
Springer
£110.34
18 Apr 2026
95% match
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
Springer
£129.22
04 Mar 2026
95% match
Immunotherapy in Translational Cancer Research (Translational Oncology)
Wiley
£135.04
24 Jan 2026
95% match
Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy
Springer
£54.12
08 Mar 2026
94% match
Cancer Immunotherapy: Immune Suppression and Tumor Growth
Academic Press
£77.00
24 Feb 2026
94% match
Cancer Immunotherapy: Immune Suppression and Tumor Growth
Academic Press
£78.99
23 Feb 2026
94% match
Springer - Resistance to Immunotherapeutic Antibodies in Cancer
Springer
£107.61
17 Apr 2026
94% match
Clinical Immuno-Oncology
Elsevier
£92.99
25 Jan 2026
94% match
Immunopharmacology
Springer
£92.56
26 Feb 2026
94% match
Academic Press - Multifaceted Role of IL-1 in Cancer and Inflammation
Academic Press
£114.57
18 Apr 2026
94% match
Inflammation and Immunity in Cancer
Springer
£112.86
08 Mar 2026
94% match
Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance
Academic Press
£98.89
09 Mar 2026
94% match
Vaccines for Cancer Immunotherapy: An Evidence-Based Review on Current Status and Future Perspectives
Academic Press
£90.96
26 Feb 2026
94% match
Cancer Immunology: Cancer Immunotherapy for Organ-Specific Tumors
Springer
£156.60
12 Jan 2026
94% match
Cancer Stem Cell Resistance to Targeted Therapy: 19 (Resistance to Targeted Anti-Cancer Therapeutics, 19)
Springer
£75.84
28 Feb 2026
94% match
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
£110.06
13 Jan 2026
94% match
Cancer Immunology: Innovative Approaches to Therapy: 27 (Cancer Treatment and Research, 27)
Springer
£146.40
24 Feb 2026
94% match
Cancer Vaccines as Immunotherapy of Cancer
Academic Press
£101.29
08 Mar 2026
94% match
Cancer Immunology: Bench to Bedside Immunotherapy of Cancers
Springer
£156.60
11 Jan 2026
94% match
Mechanisms of Tumor Escape from the Immune Response (Tumor Immunology and Immunotherapyseries, 1)
CRC Press
£79.41
08 Mar 2026
94% match
Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal
Springer
£94.01
09 Mar 2026
94% match
Cancer and Autoimmunity (Autoanitbody Library)
Elsevier
£99.60
09 Mar 2026